LifeStance Health Group, Inc. (LFST)
USD 6.8
(4.29%)
USD 6.8
(4.29%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.05 Billion USD | 22.82% |
| 2022 | 859.54 Million USD | 28.77% |
| 2021 | 667.51 Million USD | 76.96% |
| 2020 | 377.21 Million USD | 77.5% |
| 2019 | 212.51 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 300.43 Million USD | 7.07% |
| 2024 Q2 | 312.33 Million USD | 3.96% |
| 2023 Q1 | 252.58 Million USD | 10.13% |
| 2023 FY | 1.05 Billion USD | 22.82% |
| 2023 Q4 | 280.6 Million USD | 6.74% |
| 2023 Q3 | 262.89 Million USD | 1.28% |
| 2023 Q2 | 259.57 Million USD | 2.77% |
| 2022 Q3 | 217.56 Million USD | 3.83% |
| 2022 Q2 | 209.52 Million USD | 3.17% |
| 2022 Q1 | 203.09 Million USD | 6.89% |
| 2022 FY | 859.54 Million USD | 28.77% |
| 2022 Q4 | 229.36 Million USD | 5.42% |
| 2021 Q1 | 143.13 Million USD | 21.17% |
| 2021 FY | 667.51 Million USD | 76.96% |
| 2021 Q4 | 189.99 Million USD | 9.3% |
| 2021 Q3 | 173.83 Million USD | 8.28% |
| 2021 Q2 | 160.54 Million USD | 12.17% |
| 2020 Q3 | 101.98 Million USD | 124.37% |
| 2020 Q2 | 45.45 Million USD | -37.83% |
| 2020 Q1 | 73.1 Million USD | 0.0% |
| 2020 FY | 377.21 Million USD | 77.5% |
| 2020 Q4 | 118.12 Million USD | 15.83% |
| 2019 FY | 212.51 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 63.955% |
| Addus HomeCare Corporation | 1.05 Billion USD | 0.282% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -438.833% |
| Amedisys, Inc. | 2.23 Billion USD | 52.796% |
| Astrana Health, Inc. | 1.38 Billion USD | 23.87% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 44.298% |
| IMAC Holdings, Inc. | 5.19 Million USD | -20212.969% |
| biote Corp. | 185.36 Million USD | -469.521% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -3268.03% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 47.732% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -69.099% |
| The Ensign Group, Inc. | 3.72 Billion USD | 71.693% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 36.839% |
| InnovAge Holding Corp. | 763.85 Million USD | -38.202% |
| The Joint Corp. | 117.69 Million USD | -796.939% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -10091.275% |
| ModivCare Inc. | 2.75 Billion USD | 61.629% |
| NewGenIvf Group Limited | 5.13 Million USD | -20453.613% |
| Option Care Health, Inc. | 4.3 Billion USD | 75.463% |
| P3 Health Partners Inc. | 1.26 Billion USD | 16.639% |
| P3 Health Partners Inc. | 1.26 Billion USD | 16.639% |
| The Pennant Group, Inc. | 544.89 Million USD | -93.739% |
| Surgery Partners, Inc. | 2.74 Billion USD | 61.518% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -19041.205% |
| Talkspace, Inc. | 150.04 Million USD | -603.566% |
| Talkspace, Inc. | 150.04 Million USD | -603.566% |
| The Oncology Institute, Inc. | 324.23 Million USD | -225.582% |
| The Oncology Institute, Inc. | 324.23 Million USD | -225.582% |